¼¼¹Ì³ª/Çà»ç

> Á¤º¸¼¾ÅÍ > ¼¼¹Ì³ª/Çà»ç

Á¦¸ñ 2023³â 4¿ù 20ÀÏ »ý¹°Á¤º¸ÇÐ ¼¼¹Ì³ª
ÀÛ¼ºÀÚ °ü¸®ÀÚ ÀÛ¼ºÀÏ 2023-04-18

¼­¿ï´ëÇб³ »ý¹°Á¤º¸ÇÐ Çùµ¿°úÁ¤ ÁÖÃÖ·Î ¼¼¹Ì³ª¸¦ ¾Æ·¡¿Í °°ÀÌ ¿­°íÀÚ ÇÏ¿À´Ï ¸¹Àº Âü¿© ¹Ù¶ø´Ï´Ù.

¼¼¹Ì³ª´Â ZoomÀ» ÅëÇÑ ¿Â¶óÀÎ °­ÀÇ·Î ¿¹Á¤µÇ¾î ÀÖÀ¸¸ç °­ÀÇ¿¡ Âü¿©ÇÏ°íÀÚ ÇϽô ºÐ²²¼­´Â ¾Æ·¡ÀÇ ¸µÅ©·Î Âü¿© ºÎŹµå¸®°Ú½À´Ï´Ù.


*ÁÜÀ¸·Î Âü¼®Çϱâ À§Çؼ­´Â "Âü¼®ÀڷΠȸÀÇ Âü°¡" --> À̸§, ¼º, À̸ÞÀÏ ÁÖ¼Ò, À̸ÞÀÏ ÁÖ¼Ò È®ÀÎÀ» ÀÔ·ÂÇÏ½Ã°í µî·ÏÇϽøé ȸÀÇ Âü¼®ÀÌ °¡´ÉÇÕ´Ï´Ù.


ÀϽÃ: 2023³â 4¿ù 20ÀÏ ¸ñ¿äÀÏ ¿ÀÀü 11½Ã

¿¬»ç: ÃÖÁ¤±Õ ±³¼ö´Ô (KAIST)

Zoom link: https://snu-ac-kr.zoom.us/j/93026622635?pwd=d0hEM09XR05aMnExUnlPdStpcFJnZz09


Monocyte-specific regulation of ERAP2 by genetic risk factors for COVID-19 severity and autoimmune diseases


Jung Kyoon Choi

Department of Bio and Brain Engineering, KAIST, Daejeon 34141, Korea


Genetic dissection of complex diseases by genome-wide association studies indicates a role for regulatory variants. Here, we develop a computational framework for systematic modeling of risk variants mapped to open chromatin regions across 99 cell types. This model reveals significant implications of gene regulation in monocytes or macrophages for the genetic risk of COVID-19 severity and major autoimmune diseases. Single-cell eQTL mapping based on 620 PBMC samples identifies ERAP2 expression in monocytes as commonly associated with COVID-19 and autoimmune diseases. ERAP2 expression as well as the relative fraction of CD14+ or CD16+ monocytes is lower in more severe COVID-19 cases but increases upon antiviral treatment or vaccination. The variants that repress ERAP2 in monocytes increase COVID-19 severity and compromise vaccine responses while showing protective effects for autoimmune diseases. Population genetic analyses support balancing selection acting on these variants. These results suggest the medical and evolutionary implications of antigen presentation by ERAP2 in monocytes or macrophages in infectious and autoimmune diseases.